News
New strategy allows halogenated organic pollutants to be "reused"

Recently, the team of Chen Qingan, a researcher at the Dalian Institute of Chemical Physics, Chinese Academy of Sciences, has made new progress in the reuse of halogenated organic pollutants. They developed a bromide-catalyzed chlorine transfer reaction that can utilize halogenated organic pollutants as halogen sources to achieve the reuse of different

July 31, 2024
Hengrui Medicine)

Founded in 1970 and listed on the Shanghai Stock Exchange in 2000, Hengrui Medicine is an innovative international pharmaceutical enterprise focusing on the research, development, production and promotion of high-quality drugs, focusing on the research and development of new drugs in the fields of anti-tumor, metabolic diseases, autoimmune diseases, respiratory diseases, neurological diseases and other areas, and it is one of the most innovative pharmaceutical leading enterprises in China.

June 27, 2025
Chinese Academy of Sciences

The Chinese Academy of Sciences (CAS) has put forward the concept of building a national innovation system, and has successively implemented the Knowledge Innovation Project, Innovation 2020, the Pioneering Action Program and the Outline of Comprehensive and Deepening Reform, and put forward strategic research reports, such as “Embracing the Age of Knowledge Economy, and Building a National Innovation System Innovation for Development, Science and Technology Leading the Future, Innovation 2050: Science and Technology and China's Future, New Situation of Scientific and Technological Development and Strategic Choices for 2020, and other strategic research reports.

August 1, 2024
BeiGene

Bristol-Myers is a global biotechnology company focused on the development and commercialization of innovative, affordable antineoplastic drugs with the goal of improving treatment outcomes and access to medicines for patients worldwide.

August 1, 2024
Medicilon Inc

Shanghai Medicilon Biopharmaceuticals Co., Ltd. is a drug discovery and development outsourcing service company (CRO), which has established a comprehensive technical service platform in Shanghai in line with international standards, integrating compound synthesis, compound activity screening, structural biology,** chemical evaluation, pharmacokinetic evaluation, toxicology evaluation, formulation studies and new drug registration, and has been recognized by international drug regulatory authorities. MediSipia Pharmaceutical Technology (Shanghai) Co., Ltd. was founded in February 2008, focusing on preclinical pharmacokinetic and safety evaluation studies. MediSipia's animal testing facilities are accredited by AAALAC (Association for the Assessment and Accreditation of Animals International) and the China Food and Drug Administration GLP certificate, and have met the U.S. Food and Drug Administration GLP standards. Medicilon helps clients reach their goals faster with efficient and cost-effective one-stop professional services. Close

August 1, 2024
"Bald"! Microplastics can also cause hair loss

Hair loss is a "top" problem that bothers many people. Previous scientific research has shown that genetics, immunity, excessive mental stress, staying up late, and drugs (such as chemotherapy for hair loss) can cause hair loss. A recent study shows that ubiquitous microplastics can also cause hair loss.

July 31, 2024
New strategy facilitates asymmetric multicomponent coupling reactions of olefins

Professor Chen Yifeng's research group from the School of Chemistry and Molecular Engineering of East China University of Science and Technology and Ferlinga Joint Research Center for Nobel Prize Scientists has made new progress in asymmetric multi-component coupling reactions of alkenes. Relevant research was published online in the Journal of the American Chemical Society.

July 31, 2024
USTC discovers new model of interactions between organic molecules

Recently, Professor Zhang Guoqing's team at the Hefei National Research Center for Microscale Physical Sciences at the University of Science and Technology of China reported the discovery of a new mode of interaction between organic molecules: that is, a stable light-induced charge transfer complex can be formed between aromatic imides and aliphatic amines , and systematically studied the properties and formation process of the complex through steady-state and time-resolved emission spectra, absorption spectra, mass spectrometry, paramagnetic resonance spectroscopy, etc., and proved that the complex can be used for light-induced polymerization and carbon dioxide photoreduction. , UV energy storage and other fields. The result was published in Chem under the title "Trapping Highly Reactive Photo-Induced Charge-Transfer Complex Between Amine and Imide by Light".

July 31, 2024
1